News

  • 25 January 2012

    Novartis net profit falls 47%

    Novartis has reported that its fourth quarter net profit fell 47% to $1.21bn as the company felt the impact of a previously disclosed charge of $900m, relating to a forecasted...

  • 19 January 2012

    BTG receives US Voraxaze approval

    UK-based pharmaceutical company BTG has received US Food and Drug Adminsitration (FDA) approval for its Voraxaze medication, which is used to treat patients suffering from toxic levels of methotrexate due...

Close
Close
Close

Go Top